|
🐬
|
mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
Kaisa Rajala,
Juho T. Lehto,
E. Sutinen,
H. Kautiainen,
M. Myllärniemi,
T. Saarto
|
6 |
2017 |
6
🐬
|
|
🐬
|
End-of-life care of patients with idiopathic pulmonary fibrosis
Kaisa Rajala,
Juho T. Lehto,
M. Saarinen,
E. Sutinen,
T. Saarto,
M. Myllärniemi
|
6 |
2016 |
6
🐬
|
|
🐬
|
Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life
Kaisa Rajala,
Juho T. Lehto,
E. Sutinen,
H. Kautiainen,
M. Myllärniemi,
T. Saarto
|
5 |
2018 |
5
🐬
|
|
🐜
|
Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis
15 auth.
Jaana Kaunisto,
Katariina Kelloniemi,
E. Sutinen,
U. Hodgson,
Anneli Piilonen,
R. Kaarteenaho,
R. Mäkitaro,
M. Purokivi,
E. Lappi‐Blanco,
Seppo Saarelainen,
...
H. Kankaanranta,
Arja Mursu,
M. Kanervisto,
Eija-Riitta Salomaa,
M. Myllärniemi
|
5 |
2015 |
5
🐜
|
|
🐜
|
Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis.
8 auth.
Kati Mäkelä,
M. Mäyränpää,
H.-K. Sihvo,
Paula H Bergman,
E. Sutinen,
H. Ollila,
...
R. Kaarteenaho,
M. Myllärniemi
|
5 |
2020 |
5
🐜
|
|
🐜
|
Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics
21 auth.
Juulia J. Partanen,
Paavo Häppölä,
Wei Zhou,
Arto A Lehisto,
M. Ainola,
E. Sutinen,
R. Allen,
A. Stockwell,
J. Oldham,
B. Guillen-Guio,
...
C. Flores,
I. Noth,
B. Yaspan,
R. Jenkins,
L. Wain,
S. Ripatti,
M. Pirinen,
R. Kaarteenaho,
M. Myllärniemi,
M. Daly,
J. Koskela
|
5 |
2021 |
5
🐜
|
|
🐜
|
A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung
13 auth.
V. Pulkkinen,
K. Salmenkivi,
V. Kinnula,
E. Sutinen,
M. Halme,
U. Hodgson,
Juho T. Lehto,
A. Jääskeläinen,
H. Piiparinen,
J. Kere,
...
I. Lautenschlager,
M. Lappalainen,
M. Myllärniemi
|
5 |
2012 |
5
🐜
|
|
🐜
|
Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth.
8 auth.
J. Tamminen,
M. Yin,
M. Rönty,
E. Sutinen,
A. Pasternack,
O. Ritvos,
...
M. Myllärniemi,
K. Koli
|
4 |
2015 |
4
🐜
|
